Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets
Gennisium finds a strategic partner with global experience and connections in the pharmaceutical industry to accelerate its development in neonatology.
Read More